Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.

Míreanna comhchosúla

• Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
  de réir: Rolinski, M, et al.
  Foilsithe / Cruthaithe: (2012)
• Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
  de réir: Ballard, C, et al.
  Foilsithe / Cruthaithe: (2007)
• Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
  de réir: Chalmers, K, et al.
  Foilsithe / Cruthaithe: (2008)
• Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
  de réir: McShane, R, et al.
  Foilsithe / Cruthaithe: (2001)
• Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
  de réir: Shifu Xiao, et al.
  Foilsithe / Cruthaithe: (2019-02-01)